Correlation Between Pfizer and First Trust
Can any of the company-specific risk be diversified away by investing in both Pfizer and First Trust at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and First Trust into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and First Trust New, you can compare the effects of market volatilities on Pfizer and First Trust and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of First Trust. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and First Trust.
Diversification Opportunities for Pfizer and First Trust
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Pfizer and First is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and First Trust New in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on First Trust New and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with First Trust. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of First Trust New has no effect on the direction of Pfizer i.e., Pfizer and First Trust go up and down completely randomly.
Pair Corralation between Pfizer and First Trust
If you would invest 2,550 in Pfizer Inc on September 12, 2024 and sell it today you would lose (27.00) from holding Pfizer Inc or give up 1.06% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 0.4% |
| Values | Daily Returns |
Pfizer Inc vs. First Trust New
Performance |
| Timeline |
| Pfizer Inc |
| First Trust New |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Pfizer and First Trust Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and First Trust
The main advantage of trading using opposite Pfizer and First Trust positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, First Trust can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in First Trust will offset losses from the drop in First Trust's long position.| Pfizer vs. Victory Integrity Smallmid Cap | Pfizer vs. Hilton Worldwide Holdings | Pfizer vs. NVIDIA | Pfizer vs. JPMorgan Chase Co |
| First Trust vs. Voya Global Equity | First Trust vs. Blackrock Enhanced Capital | First Trust vs. Eagle Point Income | First Trust vs. European Equity Closed |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| CEOs Directory Screen CEOs from public companies around the world |